Spend £150 for 20% Off  |   Spend £500 for 30% Off

My Account

Checkout

Customer Support

Matrixyl 3000 10mg
Matrixyl 3000 10mg
Matrixyl 3000 10mg
Matrixyl 3000 10mg
Matrixyl 3000 10mg
Matrixyl 3000 10mg
Matrixyl 3000 10mg

Matrixyl 3000 10mg

£24.90

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 98.5 % (HPLC, typical)
  • CAS Number: 42464-96-0
  • Molecular Formula: C₁₀H₁₁N₂⁺
Volume Pricing
Spend £150+ (20% off)£23.12
Spend £500+ (30% off)£20.23

Spending over £1000? Email us your order and we will custom price.

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Money Back Guarantee

Guaranteed Safe Checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

Description

Description & Mechanism

Matrixyl consists of a short pentapeptide sequence covalently modified at the N-terminus with a palmitoyl fatty acid chain. This lipid conjugation increases hydrophobicity and is used in research settings to study peptide–lipid interactions, peptide stability, and extracellular matrix–associated signalling processes in cellular and formulation-based systems.

In experimental models, Matrixyl is utilised as a reference compound for investigating matrikine-related signalling, peptide uptake dynamics, and the behaviour of lipid-modified peptides in dermal or fibroblast-associated research assays. Observed molecular responses are dependent on experimental design, concentration, formulation matrix, and model system.

Applications in Research

  • As a model peptide for studying extracellular matrix–related signalling pathways
  • Investigation of lipid-conjugated peptide stability and behaviour in cellular systems
  • In vitro studies examining peptide–cell and peptide–matrix interactions
  • Reference compound in formulation, compatibility, and peptide delivery research

Handling, Reconstitution & Stability

  • Reconstitute shortly before use in DMSO, dilute acid, or suitable buffer depending on assay requirements
  • Avoid vigorous agitation during dissolution
  • Aliquot reconstituted solutions to minimise repeated freeze–thaw cycles
  • Store reconstituted peptide at 4 °C for short-term use; –20 °C or below for long-term storage
  • Protect from moisture, strong oxidisers, extreme pH, and elevated temperatures

Specifications Summary

Purity: ≥ 99 % (HPLC)
Appearance: White to off-white lyophilised powder
Peptide Length: 5 amino acids plus palmitoyl moiety
Molecular Weight: ~802.05 g/mol
CAS: 214047-00-4
Storage: –20 °C, desiccated, dark

Precautions & Notes

  • Experimental behaviour of Matrixyl is influenced by formulation matrix, concentration, and model system
  • Lipid-modified peptides may exhibit different stability and solubility profiles than non-conjugated peptides
  • Buffer composition and solvent choice can significantly affect assay performance
  • Intended strictly for laboratory research use; not for human or veterinary application

Related products